Concepedia

M. Ziemen

MZ

Statistics

Publications

15

Citations

2.4K

H-Index

14

Active since

1980

Affiliations

Sanofi (Germany)(Current)

Oregon Health & Science University

University of Perugia

Park Nicollet Clinic

Newcastle University

M. Ziemen is an author at Sanofi (Germany) specializing in medicine, diabetology, and diabetes mellitus.

Publications per year

1980–2018

15

Publications

15

Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group.

Hannele Yki‐Järvinen, A. Dressler, M. Ziemen · Diabetes Care · 2000 · 582 citations · Full text

, , +17

New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 2 Diabetes Using Basal and Mealtime Insulin: Glucose Control and Hypoglycemia in a 6-Month Randomized Controlled Trial (EDITION 1)

Matthew C. Riddle, Geremia B. Bolli, M. Ziemen et al. · Diabetes Care · 2014 · 360 citations

, , +17

New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin‐naïve people with type 2 diabetes on oral glucose‐lowering drugs: a randomized controlled trial (EDITION 3)

Geremia B. Bolli, Matthew C. Riddle, Richard M. Bergenstal et al. · Diabetes Obesity and Metabolism · 2015 · 298 citations · Full text

, , +17

New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 2 Diabetes Using Oral Agents and Basal Insulin: Glucose Control and Hypoglycemia in a 6-Month Randomized Controlled Trial (EDITION 2)

Hannele Yki‐Järvinen, Richard M. Bergenstal, M. Ziemen et al. · Diabetes Care · 2014 · 274 citations

, , +17

New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 1 Diabetes: A Randomized, Phase 3a, Open-Label Clinical Trial (EDITION 4)

Philip Home, Richard M. Bergenstal, Geremia B. Bolli et al. · Diabetes Care · 2015 · 222 citations · Full text

, , +16

1–5 of 15